We ship !

We are not shipping goods to USA
except BioBeam 940

If you are looking for safe way to treat Rheumatoid Arthritis with no pain, no drugs and no side effects, BioBeam-940 is what you need.  Biobeam-940 is Medically tested and FDA-Approved!

Click here to see a short video showing how to use Biobeam-940

Osteoarthritis is a type of arthritis which caused by the breakdown and eventual loss of the protein substance that protect between the bones of the joints. It`s also known as degenerative arthritis. There are many types of arthritis conditions while osteoarthritis is the most common one.

Osteoarthritis occurs more frequently while getting older and depends on age, it is more frequent initially in man and after 55 in female.
Osteoarthritis commonly affects the feet, hands, back as well as large weight-bearing joints as hips and knees. Most osteoarthritis cases have no known cause and are referred to as primary osteoarthritis, while if the cause of the osteoarthritis is known, the condition is referred to as secondary osteoarthritis.
Rheumatoid arthritis (RA) is a chronic, systemic inflammatory disorder that may affect many tissues and organs, but principally attacks the joints producing an inflammatory synovitis that often progresses to destruction of the articular cartilage
Various treatments are available. Pharmacological treatment includes anti-inflammatory drugs, including steroids, to suppress the symptoms, while disease-modifying antirheumatic drugs (DMARDs) are often required to inhibit or halt the underlying immune process and prevent long-term damage. In recent times, the newer group of biologics has increased treatment options.
Non-pharmacological treatment includes physical therapy and occupational therapy.
The  BioBeam 940 is effective in the treatment of Rheumatoid arthritis due to the anti-inflammatory effect.
In the last few years, phototherapy treatments led to extremely good results in various skin diseases including Rheumatologic diseases. SyroLight LtdD, which is a leading provider of phototherapeutic medical devices, managed to utilize proprietary low level narrow band light technology for the treatment of Pain and Rheumatologic diseases.

The company BioBeam 940 Light Treatment System was found particularly effective for the relief of pain in conditions such as:
Rheumatoid arthritis, Osteoarthritis (degenerative joint disease), Chondromalacia patella (changes in the cartilage of the kneecap), Chronic tendonitis (inflammation of the tendon), Chronic pain, Treatment of Rheumatologic Ailments, Joint inflammation, restricted movement, back pains and similar complaints have all been successfully treated with the BioBeam 940.

Proven Effectiveness in the Treatment of Rheumatologic Ailments
Clinical and experimental reports indicate that phototherapy has a positive effect on the treatment of pain and rheumatologic ailments including Rheumatoid arthritis while the BioBeam 940 makes use of the demonstrated therapeutic properties of narrow band light, centered at the 940 nm wavelength region of the light spectrum.

The device study conclusions were:"…The BioBeam 940 showed significant efficacy in the treatment of facet joint osteoarthritis, chronic tendonitis, degenerative knee disease and chondromalacia of the patella." "… Patients with degenerative knee disease and chondromalacia patella treated with 940 nm low level narrow band light showed a significant improvement in pain, power, and ability to negotiate stairs and walking tolerance."

The BioBeam 940 is FDA approved device.

While traditional phototherapeutic methods are often prohibitively expensive and require a clinical setting, the lightweight, portable BioBeam940 is suitable for home use.

The BioBeam 940 is a completely safe device, treatment is painless, very easy to manipulate and provides a drug free completely safe treatment in the comfort of one`s home.

ARTICLES

1: J Am Geriatr Soc. 1992 Jan;40(1):23-6.

Improvement of pain and disability in elderly patients with degenerative osteoarthritis of the knee treated with narrow-band light therapy.

Stelian J, Gil I, Habot B, Rosenthal M, Abramovici I, Kutok N, Khahil A.
Geriatric Medical Center, Shmuel Harofe Hospital, Beer Yaakov, Israel.


OBJECTIVE: To evaluate the effects of low-power light therapy on pain and disability in elderly patients with degenerative osteoarthritis of the knee.

DESIGN: Partially double-blinded, fully randomized trial comparing red, infrared, and placebo light emitters. PATIENTS: Fifty patients with degenerative osteoarthritis of both knees were randomly assigned to three treatment groups: red (15 patients), infrared (18 patients), and placebo (17 patients). Infrared and placebo emitters were double-blinded. INTERVENTIONS: Self-applied treatment to both sides of the knee for 15 minutes twice a day for 10 days. MAIN OUTCOME MEASURES: Short-Form McGill Pain Questionnaire, Present Pain Intensity, and Visual Analogue Scale for pain and Disability Index Questionnaire for disability were used. We evaluated pain and disability before and on the tenth day of therapy. The period from the end of the treatment until the patient`s request to be retreated was summed up 1 year after the trial. RESULTS: Pain and disability before treatment did not show statistically significant differences between the three groups. Pain reduction in the red and infrared groups after the treatment was more than 50% in all scoring methods (P less than 0.05). There was no significant pain improvement in the placebo group. We observed significant functional improvement in red- and infrared-treated groups (p less than 0.05), but not in the placebo group. The period from the end of treatment until the patients required treatment was longer for red and infrared groups than for the placebo group (4.2 +/- 3.0, 6.1 +/- 3.2, and 0.53 +/- 0.62 months, for red, infrared, and placebo, respectively). CONCLUSIONS: Low-power light therapy is effective in relieving pain and disability in degenerative osteoarthritis of the knee.

If you are looking for safe way to treat Rheumatoid Arthritis with no pain, no drugs and no side effects, BioBeam-940 is what you need.  Biobeam-940 is Medically tested and FDA-Approved!

Click here to see a short video showing how to use Biobeam-940

Osteoarthritis is a type of arthritis which caused by the breakdown and eventual loss of the protein substance that protect between the bones of the joints. It`s also known as degenerative arthritis. There are many types of arthritis conditions while osteoarthritis is the most common one.

Osteoarthritis occurs more frequently while getting older and depends on age, it is more frequent initially in man and after 55 in female.
Osteoarthritis commonly affects the feet, hands, back as well as large weight-bearing joints as hips and knees. Most osteoarthritis cases have no known cause and are referred to as primary osteoarthritis, while if the cause of the osteoarthritis is known, the condition is referred to as secondary osteoarthritis.
Rheumatoid arthritis (RA) is a chronic, systemic inflammatory disorder that may affect many tissues and organs, but principally attacks the joints producing an inflammatory synovitis that often progresses to destruction of the articular cartilage
Various treatments are available. Pharmacological treatment includes anti-inflammatory drugs, including steroids, to suppress the symptoms, while disease-modifying antirheumatic drugs (DMARDs) are often required to inhibit or halt the underlying immune process and prevent long-term damage. In recent times, the newer group of biologics has increased treatment options.
Non-pharmacological treatment includes physical therapy and occupational therapy.
The  BioBeam 940 is effective in the treatment of Rheumatoid arthritis due to the anti-inflammatory effect.
In the last few years, phototherapy treatments led to extremely good results in various skin diseases including Rheumatologic diseases. SyroLight LtdD, which is a leading provider of phototherapeutic medical devices, managed to utilize proprietary low level narrow band light technology for the treatment of Pain and Rheumatologic diseases.

The company BioBeam 940 Light Treatment System was found particularly effective for the relief of pain in conditions such as:
Rheumatoid arthritis, Osteoarthritis (degenerative joint disease), Chondromalacia patella (changes in the cartilage of the kneecap), Chronic tendonitis (inflammation of the tendon), Chronic pain, Treatment of Rheumatologic Ailments, Joint inflammation, restricted movement, back pains and similar complaints have all been successfully treated with the BioBeam 940.

Proven Effectiveness in the Treatment of Rheumatologic Ailments
Clinical and experimental reports indicate that phototherapy has a positive effect on the treatment of pain and rheumatologic ailments including Rheumatoid arthritis while the BioBeam 940 makes use of the demonstrated therapeutic properties of narrow band light, centered at the 940 nm wavelength region of the light spectrum.

The device study conclusions were:"…The BioBeam 940 showed significant efficacy in the treatment of facet joint osteoarthritis, chronic tendonitis, degenerative knee disease and chondromalacia of the patella." "… Patients with degenerative knee disease and chondromalacia patella treated with 940 nm low level narrow band light showed a significant improvement in pain, power, and ability to negotiate stairs and walking tolerance."

The BioBeam 940 is FDA approved device.

While traditional phototherapeutic methods are often prohibitively expensive and require a clinical setting, the lightweight, portable BioBeam940 is suitable for home use.

The BioBeam 940 is a completely safe device, treatment is painless, very easy to manipulate and provides a drug free completely safe treatment in the comfort of one`s home.

ARTICLES

1: J Am Geriatr Soc. 1992 Jan;40(1):23-6.

Improvement of pain and disability in elderly patients with degenerative osteoarthritis of the knee treated with narrow-band light therapy.

Stelian J, Gil I, Habot B, Rosenthal M, Abramovici I, Kutok N, Khahil A.
Geriatric Medical Center, Shmuel Harofe Hospital, Beer Yaakov, Israel.


OBJECTIVE: To evaluate the effects of low-power light therapy on pain and disability in elderly patients with degenerative osteoarthritis of the knee.

DESIGN: Partially double-blinded, fully randomized trial comparing red, infrared, and placebo light emitters. PATIENTS: Fifty patients with degenerative osteoarthritis of both knees were randomly assigned to three treatment groups: red (15 patients), infrared (18 patients), and placebo (17 patients). Infrared and placebo emitters were double-blinded. INTERVENTIONS: Self-applied treatment to both sides of the knee for 15 minutes twice a day for 10 days. MAIN OUTCOME MEASURES: Short-Form McGill Pain Questionnaire, Present Pain Intensity, and Visual Analogue Scale for pain and Disability Index Questionnaire for disability were used. We evaluated pain and disability before and on the tenth day of therapy. The period from the end of the treatment until the patient`s request to be retreated was summed up 1 year after the trial. RESULTS: Pain and disability before treatment did not show statistically significant differences between the three groups. Pain reduction in the red and infrared groups after the treatment was more than 50% in all scoring methods (P less than 0.05). There was no significant pain improvement in the placebo group. We observed significant functional improvement in red- and infrared-treated groups (p less than 0.05), but not in the placebo group. The period from the end of treatment until the patients required treatment was longer for red and infrared groups than for the placebo group (4.2 +/- 3.0, 6.1 +/- 3.2, and 0.53 +/- 0.62 months, for red, infrared, and placebo, respectively). CONCLUSIONS: Low-power light therapy is effective in relieving pain and disability in degenerative osteoarthritis of the knee.

 

 

$179.95

 

 

 

$179.95